The University of Queensland
FODEN has broad experience in executive and non-executive roles at both public and private companies and at funding organisations. Her current directorships include the chair of BerGenBio AS and non-executive roles at BTG plc and at Vectura Group plc. From 2000 to 2003, Susan was an investor director with the London-based venture capital firm Merlin Biosciences Limited and, from 1987 to 2000, was chief executive officer of the technology transfer company Cancer Research Campaign Technology Limited. She studied biochemistry at the University of Oxford, obtaining an MA and a DPhil.